TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18295109

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy (UGFS)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Ultrasound-guided liquid sclerotherapy (UGLS)
Number of subjects: 89
Study: 16809947

Group type: EXPERIMENTAL
Intervention: Medilac DS (Bacillus subtilis, Streptococcus faecium)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12634224

Group type: EXPERIMENTAL
Intervention: CsA plus MTX combination therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: CsA monotherapy
Number of subjects: 120
Study: 10719408

Group type: EXPERIMENTAL
Intervention: Group-based dietary fat intake intervention (11 lessons over 14 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Pretest/posttest control group (no specific intervention mentioned)
Number of subjects: 110
Study: 9367069

Group type: EXPERIMENTAL
Intervention: Oral retinol (25,000 IU) daily for up to 5 years
Number of subjects: 2297

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 2297
Study: 1588378

Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 237

Group type: COMPARATOR
Intervention: Lumpectomy plus radiation
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Irradiated breast
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Local breast failures
Number of subjects: 237
Study: 3866866

Group type: EXPERIMENTAL
Intervention: Weekly mouthrinsing with a 0.2 percent NaF solution
Number of subjects: 425

Group type: COMPARATOR
Intervention: Control group (semiannual fluoride varnish treatments)
Number of subjects: 425
Study: 28843837

Group type: EXPERIMENTAL
Intervention: US-guided intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 27612046

Group type: EXPERIMENTAL
Intervention: Retrospectively ECG-triggered acquisition CCTA at 100 kVp (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Adaptive prospective ECG-triggered sequence acquisition at 100 kVp (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Adaptive prospective ECG-triggered sequence acquisition at 80 kVp with iterative reconstruction (Group C)
Number of subjects: 120
Study: 25219106

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT) with wheat, up-dosing phase until 100 g tolerated, followed by 6-month maintenance phase
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT) with wheat
Number of subjects: 6
Study: 22872467

Group type: EXPERIMENTAL
Intervention: 4 mg E(2)
Number of subjects: 16
Study: 20968271

Group type: EXPERIMENTAL
Intervention: Quercetin supplementation (1 g/d for 6 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 18303020

Group type: EXPERIMENTAL
Intervention: sifuvirtide (5, 10, 20, 30, and 40 mg) by subcutaneous injection once daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enfuvirtide (T20)
Number of subjects: 60
Study: 16008680

Group type: COMPARATOR
Intervention: Secretor subjects (Se/Se)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Blood group O/secretor phenotype (Se/Se)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Blood group O/Le(a-b-)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Lewis Le(a-b-) recessive genotype
Number of subjects: 297

Group type: COMPARATOR
Intervention: Joint blood group O/Le(a-b-) phenotype
Number of subjects: 297
Study: 12747278

Group type: EXPERIMENTAL
Intervention: 10 mg prednisone daily
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 11191780

Group type: EXPERIMENTAL
Intervention: Error training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided error training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Errorless learning
Number of subjects: 0
Study: 8615348

Group type: EXPERIMENTAL
Intervention: High-energy, high-protein drink (atole)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Low-energy, no-protein drink (fresco)
Number of subjects: 460
Study: 1360774

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate, 12 micrograms, bid
Number of subjects: 112

Group type: COMPARATOR
Intervention: Switch from salbutamol to formoterol
Number of subjects: 112
Study: 4061119

Group type: EXPERIMENTAL
Intervention: Weight reduction program (W group, n = 24)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Weight and salt reduction program (WS group, n = 23)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Salt restriction program (S group, n = 17)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Weight reduction program (W group)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Weight and salt reduction program (WS group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Salt restriction program (S group)
Number of subjects: 64
Study: 30616570

Group type: EXPERIMENTAL
Intervention: non-invasive vagus nerve stimulation (nVNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: sham control
Number of subjects: 0
Study: 27534447

Group type: EXPERIMENTAL
Intervention: Micro-titanium stent as a facial pressure bearing device
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spontaneous healing (control group)
Number of subjects: 24
Study: 25382826

Group type: EXPERIMENTAL
Intervention: Prodrug (LY2140023) 80 mg oral
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prodrug (LY2140023) 80 mg oral and 100 μg i.v.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active moiety (LY404039) 100 μg i.v.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prodrug (LY2140023)
Number of subjects: 0
Study: 24342198

Group type: EXPERIMENTAL
Intervention: Triple therapy (HFOV, PS, iNO)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Dual therapy (HFOV, iNO)
Number of subjects: 116
Study: 21621753

Group type: EXPERIMENTAL
Intervention: Two faces looking at each other
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two faces looking away from each other
Number of subjects: 0
Study: 19363561

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 62
Study: 16460632

Group type: EXPERIMENTAL
Intervention: Aquacel covered with Tegaderm
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cutiplast
Number of subjects: 200
Study: 15308252

Group type: EXPERIMENTAL
Intervention: Gentle handling of soft tissues on the medial side of the ascending ramus (test side)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine handling of soft tissues (contralateral control side)
Number of subjects: 0
Study: 11499744

Group type: EXPERIMENTAL
Intervention: L-arginine (15 g daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9988941

Group type: EXPERIMENTAL
Intervention: DDD pacing with optimum AV delay
Number of subjects: 9

Group type: COMPARATOR
Intervention: VVI mode at ventricular 'sentinel' rate of 50 b/min
Number of subjects: 9
Study: 7528908

Group type: EXPERIMENTAL
Intervention: Interferon treatment in 17 children
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mixed viremia (wild-type and HBeAg minus HBV) in 10 children (34.5%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HBeAg minus HBV
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Wild-type HBV
Number of subjects: 30
Study: 3372288

Group type: EXPERIMENTAL
Intervention: Prenatal education program
Number of subjects: 28
Study: 29703591

Group type: EXPERIMENTAL
Intervention: Nurse-initiated radiographic-test protocol (using Ottawa Ankle Rules)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual practice (physician expertise)
Number of subjects: 112
Study: 28258526

Group type: EXPERIMENTAL
Intervention: Medication advertisement
Number of subjects: 424

Group type: COMPARATOR
Intervention: Automobile advertisement
Number of subjects: 424
Study: 25311256

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 88

Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 88
Study: 23132508

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fluid restriction (Control)
Number of subjects: 85
Study: 21575074

Group type: EXPERIMENTAL
Intervention: CwPLI
Number of subjects: 71

Group type: COMPARATOR
Intervention: CwSLI
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: CwPLI and CwSLI
Number of subjects: 71
Study: 19626555

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17009253

Group type: EXPERIMENTAL
Intervention: 0.5 mg of sCT
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 1 mg of sCT
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 15015948

Group type: EXPERIMENTAL
Intervention: Magnet attachments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bar-clip attachments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ball attachments
Number of subjects: 18
Study: 10680410

Group type: EXPERIMENTAL
Intervention: BSE skills-building workshop
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched sexually transmitted diseases prevention workshop
Number of subjects: 0
Study: 9077495

Group type: EXPERIMENTAL
Intervention: Polymyositis (PM) patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Other neuromuscular diseases (ONMD) patients
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: TNF-alpha positive muscles
Number of subjects: 14
Study: 8447841

Group type: EXPERIMENTAL
Intervention: Radioimmunoassay (RIA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Gas Chromatographic/Mass Spectrometric (GC/MS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: High Pressure Liquid Chromatography (HPLC) combined with RIA
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Modifications of the radioimmunoassay procedure
Number of subjects: 51
Study: 3114548

Group type: EXPERIMENTAL
Intervention: Bupranolol 100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29972647

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (monthly treatment)
Number of subjects: 702
Study: 27018941

Group type: EXPERIMENTAL
Intervention: Doxycycline (100mg bid)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study: 24029546

Group type: EXPERIMENTAL
Intervention: Oral laquinimod (0.6 mg)
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1106
Study: 22939094

Group type: EXPERIMENTAL
Intervention: Animated formats (text/numbers, pie chart, bar graph, pictograph)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preference match (format matched to individual preference)
Number of subjects: 100
Study: 20503023

Group type: EXPERIMENTAL
Intervention: Pegylated interferon plus ribavirin (800-1200 mg/d)
Number of subjects: 219
Study: 18154911

Group type: EXPERIMENTAL
Intervention: 12-week graded exercise program
Number of subjects: 34

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 34
Study: 16802892

Group type: EXPERIMENTAL
Intervention: Implementation intentions (experimental condition)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 300
Study: 14617458

Group type: EXPERIMENTAL
Intervention: Ovarian surgery (including unilateral oophorectomy, ovarian wedge resection, and ovarian drilling)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 19
Study: 10882164

Group type: EXPERIMENTAL
Intervention: Tropisetron monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of dexamethasone and tropisetron
Number of subjects: 0

Group type: COMPARATOR
Intervention: High dose metoclopramide plus dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tropisetron and ondansetron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tropisetron
Number of subjects: 0
Study: 9496217

Group type: EXPERIMENTAL
Intervention: methohexitone-alfentanil
Number of subjects: 24

Group type: COMPARATOR
Intervention: methohexitone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: propofol-alfentanil
Number of subjects: 24

Group type: COMPARATOR
Intervention: propofol
Number of subjects: 24
Study: 8439022

Group type: EXPERIMENTAL
Intervention: Droperidol (30 micrograms/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Menstrual group (days 1-8)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nonmenstrual group (days 9-28)
Number of subjects: 100
Study: 3513644

Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulfadoxine (SP)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 198

Group type: COMPARATOR
Intervention: Amodiaquine
Number of subjects: 198
Study: 31784365

Group type: EXPERIMENTAL
Intervention: Leukocyte-rich platelet-rich plasma (PRP) injection
Number of subjects: 97

Group type: COMPARATOR
Intervention: Normal saline injection (Control)
Number of subjects: 97
Study: 30528317

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment (2%) dressings
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard gauze dressings
Number of subjects: 150
Study: 28753098

Group type: EXPERIMENTAL
Intervention: CAF + CM
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CAF + EMD
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CAF + CM + EMD
Number of subjects: 68

Group type: COMPARATOR
Intervention: CAF
Number of subjects: 68
Study: 25510856

Group type: EXPERIMENTAL
Intervention: Clarithromycin (CYP3A4 inhibitor)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clarithromycin + Paroxetine (CYP3A4 + CYP2D6 inhibitors)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: O‐desmethylvenlafaxine/venlafaxine > 4
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: O‐desmethylvenlafaxine < 4 and venlafaxine + O‐desmethylvenlafaxine > 400 ng/ml
Number of subjects: 24
Study: 22926014

Group type: EXPERIMENTAL
Intervention: Primary tumour resection
Number of subjects: 216

Group type: COMPARATOR
Intervention: No primary tumour resection
Number of subjects: 216
Study: 21300298

Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 450

Group type: COMPARATOR
Intervention: CRT OFF
Number of subjects: 450
Study: 19147401

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: OSAS patients
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OSAS treatment (CPAP and MAD)
Number of subjects: 24
Study: 16903598

Group type: EXPERIMENTAL
Intervention: Substance-partitioned moxibustion at Guanyuan (CV 4) and Shenque (CV 8), once a day for 3 menstrual cycles
Number of subjects: 138

Group type: COMPARATOR
Intervention: Oral administration of Yueyueshu Powder, twice a day, 10 g each time for 3 menstrual cycles
Number of subjects: 138
Study: 15509188

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 0
Study: 11393608

Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination (EDE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination Questionnaire (EDE-Q)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-monitoring of eating behaviors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EDE-Q and self-monitoring
Number of subjects: 0
Study: 9251274

Group type: EXPERIMENTAL
Intervention: ACTHIB vaccine given with primary immunization (age group 6 to 8 weeks) in 50 babies
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: ACTHIB vaccine
Number of subjects: 172
Study: 8104070

Group type: COMPARATOR
Intervention: High-dose cyclophosphamide (HD-CY; 7 g/m2) alone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (HD-CY; 7 g/m2) with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF; 5 micrograms/kg/day iv after HD-CY)
Number of subjects: 31
Study: 3006471

Group type: EXPERIMENTAL
Intervention: High sucrose diet (36% sucrose) with low fiber
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High sucrose diet (52% sucrose) with low fiber
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High sucrose diet (36% sucrose) with high fiber
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High sucrose diet (52% sucrose) with high fiber
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low sucrose diets (0% and 18% sucrose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All low fat diets
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Very high carbohydrate diets with fiber
Number of subjects: 24
Study: 31971832

Group type: EXPERIMENTAL
Intervention: Functional Training (FT) (n = 14)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Interdisciplinary Therapy (IT) (n = 19)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Interdisciplinary Education (IE) (n = 11)
Number of subjects: 44
Study: 31014313

Group type: EXPERIMENTAL
Intervention: Behavioural intervention to increase walking during the commute, implemented over 10 weeks with various behavioural change techniques.
Number of subjects: 654

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 654
Study: 28489508

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 90
Study: 25927626

Group type: EXPERIMENTAL
Intervention: Unprotected non-weight-bearing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protected weight-bearing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unprotected weight-bearing
Number of subjects: 0
Study: 23014796

Group type: EXPERIMENTAL
Intervention: BFR + Exercise (unilateral knee extensions at 30% of 1RM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CON + Exercise (exercise without BFR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: BFR (rest with BFR applied)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CON (rest without treatment)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: BFR + Exercise
Number of subjects: 16
Study: 21574667

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 300
Study: 19363237

Group type: EXPERIMENTAL
Intervention: Sclerovit (1 capsule)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sclerovit (2 capsules)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17107542

Group type: EXPERIMENTAL
Intervention: Gutta‐percha cones and AH 26 with smear layer (Group 1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Gutta‐percha cones and AH 26 without smear layer (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Resilon cones and Epiphany sealer without smear layer (Group 3)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fluid transport model (all groups)
Number of subjects: 120
Study: 12742986

Group type: EXPERIMENTAL
Intervention: Ischemia modified albumin (IMA) measured by albumin cobalt binding (ACB) test after PCI
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ischemia modified albumin (IMA) in control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 8-iso prostaglandin F2-A (iP) after PCI
Number of subjects: 30

Group type: COMPARATOR
Intervention: 8-iso prostaglandin F2-A (iP) in control group
Number of subjects: 30
Study: 10965289

Group type: EXPERIMENTAL
Intervention: Fluoxetine and behavioral treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 120
Study: 8857862

Group type: EXPERIMENTAL
Intervention: Topical 60% DMSO applied every 4 hours for 10 days after operation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (operation alone)
Number of subjects: 51
Study: 1536829

Group type: EXPERIMENTAL
Intervention: Two Gabor patches with different spatial frequencies identified in parallel when occupying the same spatial position.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two Gabor patches with the same spatial frequency identified in parallel even when separated by 8 degrees.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two Gabor patches with different spatial frequencies separated by 4 degrees or more.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Performance on double-task experiment compared to single-task performance.
Number of subjects: 0
Study: 6369520

Group type: EXPERIMENTAL
Intervention: Single-dose group (500 mg of tinidazole intravenously preoperatively)
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: 3-day group (500 mg of tinidazole intravenously preoperatively + 3-day tinidazole treatment)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 588
Study: 30696686

Group type: EXPERIMENTAL
Intervention: Multicomponent non-pharmacological delirium prevention intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delirium screening and diagnostic assessment (Control)
Number of subjects: 40
Study: 28525636

Group type: EXPERIMENTAL
Intervention: Movement group (unimanual pattern of five sequential keystrokes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rest group (sat quietly without moving)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 26701166

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine perinatal care
Number of subjects: 46
Study: 24705588

Group type: COMPARATOR
Intervention: PC1/3 activity in T2D patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intact proinsulin (IPI) levels in T2D patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: IPI/C-peptide ratio in T2D patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: C-peptide responses to glucagon in T2D patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: PC2 activity in T2D patients
Number of subjects: 18
Study: 22659072

Group type: EXPERIMENTAL
Intervention: CBT4BN (Internet-based cognitive-behavioral therapy)
Number of subjects: 180

Group type: COMPARATOR
Intervention: CBTF2F (traditional face-to-face cognitive-behavioral therapy)
Number of subjects: 180